Stock SAGENT PHARMACEUTICALS INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Company Sagent Pharmaceuticals Inc

Equities

US7866921031

Pharmaceuticals

End-of-day quote Nasdaq
Other stock markets
- USD - Intraday chart for Sagent Pharmaceuticals Inc
2016 Allergan : Teva, Allergan win U.S. antitrust approval for generics deal RE

Managers

Managers TitleAgeSince
Jeffrey W. Greve DFI
 Director of Finance/CFO 49 11-01-31
Jerry Webb COO
 Chief Operating Officer - 17-12-31
Donald R. Bullock PRN
 Corporate Officer/Principal - 06-12-31

Members of the board

Members of the board TitleAgeSince
Frank Kung BRD
 Director/Board Member 75 06-04-30

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 32,910,475 32,180,075 ( 97.78 %) 0 97.78 %

Company contact information

Sagent Pharmaceuticals, Inc.

1901 North Roselle Road Suite 450

60195, Schaumburg

+

http://www.sagentpharma.com
address Sagent Pharmaceuticals Inc

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Other Pharmaceuticals

Sector Other Pharmaceuticals

1st Jan change Capi.
ELI LILLY AND COMPANY Stock Eli Lilly and Company
+26.47% 664B
NOVO NORDISK A/S Stock Novo Nordisk A/S
+26.74% 567B
JOHNSON & JOHNSON Stock Johnson & Johnson
-6.33% 354B
MERCK & CO., INC. Stock Merck & Co., Inc.
+19.35% 330B
ABBVIE INC. Stock AbbVie Inc.
+4.23% 286B
ASTRAZENECA PLC Stock AstraZeneca PLC
+13.43% 234B
NOVARTIS AG Stock Novartis AG
+4.71% 199B
ROCHE HOLDING AG Stock Roche Holding AG
-9.53% 196B
AMGEN INC. Stock Amgen Inc.
-4.04% 148B
Other Pharmaceuticals
  1. Stock Market
  2. Equities
  3. Stock
  4. Company Sagent Pharmaceuticals Inc